Ireland: Can probiotics improve Pacific oyster production?

게시됨 2021년 3월 26일

Tridge 요약

Researchers at NOAA’s Milford Laboratory have discovered a beneficial strain of Vibrio alginolyticus, named OY15, which when used as a probiotic can improve survival and disease resistance of eastern oyster larvae by 20-35 percent. This method is an alternative to the repeated use of antibiotics and is environmentally friendly. The research is being supported by a 2021 ICAF grant and will be extended to Pacific oysters. The probiotic is being supplied by Prospective Research, a company founded by participants of Ireland’s first Aquaculture Accelerator program.
면책 조항: 위의 요약은 정보 제공 목적으로 Tridge 자체 학습 AI 모델에 의해 생성되었습니다.

원본 콘텐츠

Bacterial disease in commercial oyster hatcheries is a major cause of larval mortalities, a major constraint in oyster production. Environmentally-friendly methods for controlling microbial pathogenesis with probiotic bacteria are becoming increasingly preferred over repeated use of antibiotics, which can select for resistant pathogens in the environment. NOAA’s Milford Laboratory in Connecticut has discovered and developed a benign strain of Vibrio alginolyticus isolated from the digestive glands of oysters, to manage bacterial shellfish pathogens in commercial hatcheries and improve larval survival of the eastern oyster (Crassostrea virginica). Their research has shown that adding the probiotic, called OY15, every other day as a supplement to their algal feed can improve survival and disease resistance of eastern oyster larvae by 20-35 percent when challenged with a known shellfish pathogen. NOAA’s Milford Laboratory recently secured a 2021 ICAF grant to allow hatchery-scale ...
출처: Thefishsite

더 깊이 있는 인사이트가 필요하신가요?

귀사의 비즈니스에 맞춤화된 상세한 시장 분석 정보를 받아보세요.
'쿠키 허용'을 클릭하면 통계 및 개인 선호도 산출을 위한 쿠키 제공에 동의하게 됩니다. 개인정보 보호정책에서 쿠키에 대한 자세한 내용을 확인할 수 있습니다.